X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-16 | SWTX | Schwartz Jeffrey Lawrence | Dir | S - Sale | $28.50 | -1,750,000 | 3,087,231 | -36% | -$49,875,000 | ||||||
2023-03-15 | SWTX | Hambleton Julie | Dir | S - Sale | $31.50 | -1,106 | 4,818 | -19% | -$34,841 | ||||||
2023-01-26 | SWTX | Pichl Daniel | Chief People Officer | S - Sale | $31.00 | -858 | 35,203 | -2% | -$26,598 | ||||||
2022-09-12 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $31.96 | -153,897 | 5,599,842 | -3% | -$4,919,148 | ||||||
| M | 2022-08-08 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $38.11 | -274,568 | 5,753,739 | -5% | -$10,464,363 | |||||
2021-10-20 | SWTX | Islam Saqib | CEO | S - Sale | $58.67 | -10,083 | 779,218 | -1% | -$591,527 | ||||||
| M | 2021-10-18 | SWTX | Islam Saqib | CEO | S - Sale | $58.65 | -52,417 | 769,135 | -6% | -$3,074,378 | |||||
| D | 2021-10-13 | SWTX | Smith L. Mary | Chief Development Officer | S - Sale+OE | $55.97 | -10,000 | 167,511 | -6% | -$559,675 | |||||
2021-08-10 | SWTX | Bain Capital Life Sciences Investors, LLC | 10% | S - Sale | $70.25 | -1,000,000 | 4,832,413 | -17% | -$70,250,000 | ||||||
| M | 2021-07-19 | SWTX | Islam Saqib | CEO | S - Sale | $76.56 | -62,500 | 821,552 | -7% | -$4,785,189 | |||||
| D | 2021-07-13 | SWTX | Smith L. Mary | Chief Development Officer | S - Sale+OE | $80.88 | -10,000 | 167,511 | -6% | -$808,777 | |||||
2021-07-01 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $85.01 | -15,959 | 6,028,307 | 0% | -$1,356,675 | ||||||
2021-07-01 | SWTX | Edris Badreddin | COO | S - Sale | $85.35 | -32,000 | 301,541 | -10% | -$2,731,088 | ||||||
2021-06-28 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $85.17 | -6,502 | 6,044,266 | 0% | -$553,775 | ||||||
| M | 2021-06-23 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $85.19 | -56,634 | 6,050,768 | -1% | -$4,824,541 | |||||
2021-06-10 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $85.09 | -30,852 | 6,107,402 | -1% | -$2,625,197 | ||||||
| M | 2021-06-07 | SWTX | Orbimed Advisors LLC | 10% | S - Sale | $85.36 | -48,053 | 6,138,254 | -1% | -$4,101,908 | |||||
| M | 2021-04-27 | SWTX | Squinto Stephen P | Dir, 10% | S - Sale | $76.19 | -19,432 | 125,728 | -13% | -$1,480,522 | |||||
| M | 2021-04-19 | SWTX | Islam Saqib | CEO | S - Sale | $68.02 | -62,500 | 884,052 | -7% | -$4,251,106 | |||||
| M | 2021-04-14 | SWTX | Squinto Stephen P | Dir, 10% | S - Sale | $75.04 | -1,568 | 145,160 | -1% | -$117,655 | |||||
| D | 2021-04-13 | SWTX | Smith L. Mary | Chief Development Officer | S - Sale+OE | $68.07 | -10,000 | 167,511 | -6% | -$680,723 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |